During discharge teaching for a client with kidney disease, what does the nurse teach the client to do?

Graft-versus-host disease(GVHD) is a complex immunological phenomenon occurring after allogeneic hematopoietic stem cell transplantation. It occurs when immunocompetent donor T-lymphocytesrecognize the recipient’s HLA antigens as foreign. This leads to a systemic cytotoxic immune responsedirected against the host's tissues, primarily affecting the skin, liver, and gastrointestinal tract, causing significant morbidity and potential mortality.

Rationale:

A.Comparing GVHD to a transfusion reaction is scientifically imprecise. A transfusion reaction typically involves the recipient's antibodies attacking the donor's red blood cells. In contrast, GVHD involves a cellular immune response where the graft itself becomes the aggressor against the host. This fundamental difference in the "attacker" and the "target" is a crucial distinction.

B.Stating that the patient's cells are fighting donor cells describes a classic transplant rejection. In rejection, the host's immune system identifies the graft as foreign and attempts to destroy it. GVHD is the functional opposite, where the donor’s immune cells survive the conditioning regimen and mount an attack against the immunocompromised recipient.

C.The nurse correctly explains that the donor's cellsare attacking the patient's cells. This is the hallmark of GVHD, where donor T-cells initiate an inflammatory cascade against host tissues. This explanation accurately conveys the unique "upside-down" nature of this immune complication, where the transplanted tissue perceives the host's body as the foreign invader.

D.Stating that donor cells "take over" due to immunosuppression is a vague and misleading simplification. While donor cells are intended to engraft and produce new blood cells, the term "taking over" does not explain the pathological destruction of host organs. The issue is not the presence of donor cells, but their aggressive, inappropriate immune activation.

Sickle cell disease(SCD) involves the production of abnormal hemoglobin S, which causes erythrocytes to become rigid and crescent-shaped under stress. This leads to vaso-occlusive crises, where trapped cells cause ischemia and infarction in tissues and bones. The resulting pain is often excruciating and requires aggressive analgesic managementwith opioids to maintain the patient's functional status and physiological stability during the crisis.

Rationale:

A.Telling the client it is too early for medication ignores the subjective nature of pain and the physiological intensity of a vaso-occlusive crisis. Patients with SCD often develop a high tolerance to opioids and may require frequent dosing to manage breakthrough pain. Dismissing the client's request can damage the therapeutic relationship and lead to uncontrolled pain.

B.Giving the pain medication when the dose is due is the best action. The nurse must prioritize the client's report of pain, as pain is whatever the patient says it is. In a sickle cell crisis, managing the severe ischemia is paramount, and the nurse must advocate for adequate analgesia rather than making judgmental assumptions about drug-seeking behavior.

C.Instructing the client not to request medication early is dismissive and fails to address the underlying cause of the distress. It assumes the client's request is behavioral rather than a reflection of unmet physiological needs. Effective pain management in SCD requires a collaborative approach to ensure the patient's pain is consistently controlled.

D.Requesting a placebo is unethical and a violation of professional nursing standards. Using placebos to "test" for pain or addiction is deceptive and erodes the trust between the patient and the healthcare team. In a sickle cell crisis, the pain is rooted in tissue hypoxia, and the use of placebos is medically and ethically inappropriate.